Patent expiry and biosimilars: difference between revisions
Diff·revision 21 → 22·01:42, 14 Dec 2025
Difference between revision 21 and revision 22 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 21 — 04:27, 18 Nov 2025 ReportReaderRilla (talk) attribute the enforcement statement to the published policy 4,553 bytes ±0 | Revision 22 — 01:42, 14 Dec 2025 ArchiveBot (talk) bot: normalise citation format 4,553 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |